SBI Securities’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.1K Sell
55
-1
-2% -$462 ﹤0.01% 1394
2026
Q1
$26.9K Sell
56
-359
-87% -$184K ﹤0.01% 1332
2025
Q4
$233K Buy
415
+338
+439% +$192K 0.01% 589
2025
Q3
$39.6K Sell
77
-12
-13% -$5.24K ﹤0.01% 1174
2025
Q2
$27.9K Sell
89
-9
-9% -$2.7K ﹤0.01% 1279
2025
Q1
$29.9K Buy
98
+5
+5% +$1.68K ﹤0.01% 1177
2024
Q4
$30.9K Buy
+93
New +$31.5K ﹤0.01% 1156

Other funds holding MEDP

SBI Securities's MEDP Position: Q2 2026 in Review

SBI Securities reduced its Medpace (MEDP) stake by 1.8% in Q2 2026, selling an estimated $462 and leaving 55 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1394.

SBI Securities first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $233K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • SBI Securities held 55 shares of Medpace worth $29.1K as of Q2 2026.
  • SBI Securities sold 1 Medpace share in Q2 2026, an estimated $462.
  • Medpace made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1394 holding.
  • SBI Securities first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Medpace position peaked at $233K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.